About Omaroon
Dedicated to revolutionizing PKU care through innovative medical device solutions.
Our Mission
At Omaroon, we're developing groundbreaking solutions for individuals with Phenylketonuria (PKU). Our innovative device aims to transform how PKU is managed, providing better outcomes and improved quality of life for patients worldwide.
Through collaboration with leading medical institutions and support from prestigious organizations, we're making significant strides in medical device innovation.
Our Journey
2025
MVP Launch
2024
NSF SBIR Phase II Award (Active)
2023
Initiated FDA and regulatory activities
2022
Validation study completed; NSF SBIR Phase I success
2021
Joined CTIP portfolio
2021
NSF SBIR Phase I Award
Our Team
Research & Development
Our R&D team works tirelessly to develop innovative solutions for PKU management.
Medical Partnerships
Working closely with leading medical institutions to ensure the highest standards.
Regulatory Affairs
Ensuring compliance and safety through rigorous FDA approval processes.